• 1
    DiMartini AF, Dew MA, Trzepacz PT. Organ transplantation. In: LevensonJL, ed. Textbook of Psychosomatic Medicine. Washington , DC : APPI, 2005: 675700.
  • 2
    Lim JK, Keeffe EB. Liver transplantation for alcoholic liver disease: Current concepts and length of sobriety. Liver Transpl 2004; 10: S31S38.
  • 3
    Levenson JL, Olbrisch ME. Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. Psychosomatics 1993; 34: 314323
  • 4
    Shapiro PA, Williams DL, Foray AT, Gelman IS, Wukich N, Sciacca R. Psychosocial evaluation and prediction of compliance problems and morbidity after heart transplantation. Transplantation 1995; 60: 14621466.
  • 5
    Bunzel B, Laederach-Hofmann K. Solid organ transplantation: Are there predictors for post transplant noncompliance?: A literature overview. Transplantation 2000; 70: 711715.
  • 6
    Dew MA, DiMartini AF, Steel J et al. Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl 2008; 14: 159172.
  • 7
    Gedaly R, McHugh PP, Johnston TD et al. Predictors of relapse to alcohol and illicit drugs after liver transplantation for alcoholic liver disease. Transplantation 2008; 86: 10901095.
  • 8
    Lucey MR. Management of alcoholic liver disease. Clin Liver Dis 2009; 13: 267275.
  • 9
    Weinrieb RM, Lucey MR. Treatment of addictive behaviors in liver transplant patients. Liver Transpl 2007; 13: S79S82.
  • 10
    Day E, Best D, Sweeting R et al. Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure. Liver Transpl 2008; 14: 16091613.
  • 11
    Weinrieb RM, Van Horn DHA, McLellan AT, Lucey MR. Interpreting the significance of drinking by alcohol-dependent liver transplant patients: Fostering candor is the key to recovery. Liver Transpl 2000; 6: 769776.
  • 12
    Erim Y, Böttcher M, Dahmen U, Beck O, Broelsch CE, Helander A. Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation. Liver Transpl 2007; 13: 757761.
  • 13
    Rinck D, Frieling H, Freitag A et al. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients. Drug Alcohol Depend 2007; 89: 6065.
  • 14
    DiMartini A, Day N, Lane T, Beisler A, Dew MA, Anton R. Carbohydrate deficient transferring in abstaining patients with end-stage liver disease. Alcohol Clin Exp Res 25: 17291733.
  • 15
    Levy S, Sherritt L, Vaughan BL, Germak M, Knight JR. Results of random drug testing in an adolescent substance abuse program. Pediatrics 2007; 119: 843848.
  • 16
    Baumgartner A, Jones P, Baumgartner W, Black T. Radioimmunoassay of hair for determining opiate-abuse histories. J Nucl Med 1978; 20: 748752.
  • 17
    Gandhi M, Ameli N, Bacchetti P et al. Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS 2009; 23: 471478.
  • 18
    Skopp G, Schmitt G, Pötsch L, Drönner P, Aderjan R, Mattern R. Ethyl glucuronide in human hair. Alcohol 2000 MayJun; 35: 283285.
  • 19
    Concheiro M, Cruz A, Mon M et al. Ethylglucuronide determination in urine and hair from alcohol withdrawal patients. J Anal Toxicol 2009; Apr; 33: 155161.
  • 20
    Marques P, Tippetts A, Branch D. Cocaine in the hair of mother-infant pairs: Quantitative analysis and correlations with urine measures and self-reports. Am J Drug Alcohol Abuse 1993; 19: 159175.
  • 21
    Mieczkowski T, Newel R. Patterns of concordance between hair assays and urinanalysis for cocaine: Longitudinal analysis of probationers in Pinellas County Florida, in NIDA Research Monograph (#167). The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates. pp. 161199 (1997).
  • 22
    McLellan AT, Cacciola JS, Zanis D. The Addiction Severity Index-“Lite” (ASI-“Lite”). Center for the Studies of Addiction, University of Pennsylvania, Philadelphia VA Medical Center, 1997.
  • 23
    Jurado C, Kintz P, Menéndez M, Repetto M. Influence of the cosmetic treatment of hair on drug testing. Int J Leg Med 1997; 110: 159163.
  • 24
    Moore C, Deitermann D, Lewis D, Feeley B, Niedbala RS. The detection of cocaine in hair specimens using micro-plate enzyme immunoassay. J Forensic Sci 1999; 44: 609612.
  • 25
    Negrusz A, Moore C, Deitermann D et al. Highly sensitive micro-plate enzyme immunoassay screening and NCI-GC-MS confirmation of flunitrazepam and its major metabolite 7-aminoflunitrazepam in hair. J Anal Toxicol 1999; Oct; 23: 429435.
  • 26
    Bean P. New findings with ethyl glucuronide testing in hair samples. Am Biotech Lab 2008; 26: 2021.
  • 27
    Morini L, Politi L, Acito S, Groppi A, Polettini A. Comparison of ethyl glucuronide in hair with carbohydrate-deficient transferrin in serum as markers of chronic high levels of alcohol consumption. Forensic Sci Int 2009; 188: 140143.
  • 28
    Stewart SH, Reuben A, Brzezinski WA et al. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol 2009 SepOct; 44: 464467. Epub 2009 Jun 17.
  • 29
    SAS version 9.1.3 (2002–2003). Cary, NC: SAS Institute.
  • 30
    Crosby RD, Carlson GA, Specker SM. Simulation of drug use and urine screening patterns. J Addict Dis 2003; 22: 8998.
  • 31
    DuPont RL, Griffin DW, Siskin BR, Shiraki S, Katze E, Random drug tests at work: The probability of identifying frequent and infrequent users of illicit drugs. J Addict Dis 1995; 14: 117.
  • 32
    Tanaka S, Lio R, Chinaka S, Takayama N, Hayakawa A. Identification of reaction products of methamphetamine and hydrogen peroxide in hair dye and decolorant treatments by high performance liquid chromatography/mass spectrometry. Biomed Chromatog 2001; 15: 4549.
  • 33
    Rollins D. Role of melanin in drug incorporation into hair. Society of Hair Testing, Arlington Heights , IL ; 2004.
  • 34
    Garcia-Bournissen F, Moller M, Nesterenko M, Karaskov T, Koren G. Pharmacokinetics of disappearance of cocaine from hair after discontinuation of drug use. Forensic Sci Int 2009 Aug 10; 189: 2427.
  • 35
    Kintz P, Bundeli P, Brenneisen R, Ludes B. Dose-concentration relationships in hair from subjects in a controlled heroin-maintenance program. J Anal Toxicol 1998 MayJun; 22: 231236.